Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies
Go back to Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies| (NASDAQ: AUTL) | Delayed: 1.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.58 | 52 Week High | $ | |||
| Open | $1.60 | 52 Week Low | $ | |||
| Day High | $1.72 | P/E | N/A | |||
| Day Low | $1.57 | EPS | $ | |||
| Volume | 1,442,603 | |||||

